key: cord-0078839-mmtbo68j
authors: Collard, Didier; Stronks, Karien; Harris, Vanessa; Coyer, Liza; Brinkman, Kees; Beudel, Martijn; Bokhizzou, Nejma; Douma, Renee A.; Elbers, Paul; Galenkamp, Henrike; ten Wolde, Marije; Prins, Maria; van den Born, Bert-Jan H.; Agyemang, Charles
title: Ethnic differences in COVID-19 hospitalization and hospital outcomes in a multi-ethnic population in the Netherlands
date: 2022-05-17
journal: Open Forum Infect Dis
DOI: 10.1093/ofid/ofac257
sha: b173e05776c37247d2d9beb3d571a3edcdb627c3
doc_id: 78839
cord_uid: mmtbo68j

BACKGROUND: Evidence from the US and UK suggests that ethnic minority populations are at an increased risk for developing severe COVID-19, however data from other West-European countries are scarce. METHODS: We analysed data from 1439 patients admitted between February 2020 and January 2021 to four main hospitals in Amsterdam and Almere, the Netherlands. Differences in the risk for hospitalization were assessed by comparing demographics to the general population. Using a population-based cohort as reference, we determined differences in the association between comorbidities and COVID-19 hospitalization. Outcomes following hospitalization were analysed using Cox-regression. RESULTS: The hospitalization risk was higher in all ethnic minority groups than in those of Dutch origin, with age-adjusted odds ratios ranging from 2.2(95%CI, 1.7-2.6) in Moroccans to 4.5(95%CI 3.2-6.0) in Ghanaians. Hypertension and diabetes were similarly associated with COVID-19 hospitalization. For all other comorbidities, we found differential associations. ICU-admission and mortality during 21-day follow-up following hospitalization was comparable between ethnicities. CONCLUSIONS: The risk of COVID-19 hospitalization was higher in all ethnic minority groups compared to the Dutch, but the risk of adverse outcomes following hospitalization was similar. Our results suggest that these inequalities may in part be attributable to comorbidities that can be prevented by targeted public health prevention measures. More work is needed to gain insight into the role of other potential factors such social determinants of health, which might have contributed to the ethnic inequalities in COVID-19 hospitalization.

shown that cardiovascular risk factors, which have been shown to be differentially distributed 12 across ethnic groups, are important predictors for adverse outcomes in hospitalized COVID-13 19 patients. [9] Health inequalities in access to or quality of healthcare provides additional 14 explanations for the increased risk of severe COVID-19 disease in ethnic minorities. [10, 11] 15 At present, it is unknown if the same observations translate to other Western European 16 countries; where factors such as comorbidities or access to health care that may affect the 17 severity of the COVID-19 disease, could be differentially distributed between ethnic groups. 18 In addition, it is unknown whether the impact of comorbidities on disease severity might 19 differ between ethnic groups. We aimed to understand how the severity of COVID-19 disease 20 differs between ethnic groups in a population living in Amsterdam and its neighbouring city 21 Almere, the Netherlands. We assessed ethnic inequalities in 1) the risk of COVID-19 22 hospitalization, 2) the relation between comorbidities and hospitalization, and 3) adverse 23 clinical outcomes following hospitalization. CovidPredict is a Dutch multicentre initiative to collect clinical data of hospitalized COVID-3 19 patients. [12] For this analysis, we included data from Amsterdam UMC, Flevo Hospital, 4 BovenIJ and OLVG hospitals, which together form all the general and university hospitals in To assess differences in COVID-19 hospitalization between ethnic group, we used 23 population tables from Amsterdam and Almere generated by Statistics Netherlands to serve as 24 denominator.

[17] Finally, we used data from participants from the HELIUS (Healthy Life in

an Urban Setting) study, as control population. 15 The aims and design of the HELIUS study 1 have been described elsewhere. 15 In short, HELIUS is a population-based cohort study, which 2 aims to unravel the causes of inequalities in health between ethnic groups. It contains the data 3 of ~24,000 individuals, aged between 18 and 70 years at baseline (2011-2015; physical exam 4 and questionnaire), who were sampled randomly from the Amsterdam municipality register, 5 stratified by ethnic background.

[18] For these analyses, participants of Dutch, Surinamese, 6 Turkish, Moroccan and Ghanaian ethnic origin were included. In HELIUS, participants of 7 Surinamese ethnic origin were further classified into South-Asian Surinamese, African 8 Surinamese and other based on self-report. In order to compare cases to controls, in both the 9 CovidPredict and the HELIUS, we defined for the HELIUS cohort history of hypertension as 10 the use of blood pressure lowering medication. Chronic pulmonary disease was defined as the 11 use of either inhaled corticosteroids or bronchodilating drugs. Obesity was defined as a body 12 mass index larger than 30 kg/m 2 . Diabetes was defined based on medication use, fasting 13 glucose levels above 7 mmol/L or a self-reported history of diabetes. Chronic kidney disease 14 was defined as either albuminuria (urinary albumin:creatinin ratio >30 mg/g) or an estimated 15 glomerular filtration rate of less than or equal to 60 ml/min/1.73 m 2 based on the CKD-EPI 16 formula.[19] Current or previous malignancy was based on self-reported history obtained 17 from the questionnaire.

Study outcomes 20 First, we analysed ethnic differences in the odds for COVID-19 related hospitalization using 21 the general population of Amsterdam and Almere as the denominator. Secondly, we 22 performed a case-control study to evaluate the relationship between comorbidities and the risk 23 for hospitalization per ethnic group. Thirdly, we investigated ethnic differences in the risk for 24 ICU admission and mortality following hospital admission. For the latter, we performed a 25 A C C E P T E D M A N U S C R I P T 6 survival analysis starting from the hospitalization. We used mortality as primary outcome, and 1 the composite outcome of ICU-admission and mortality as secondary outcome. Mortality was 2 defined as either hospital mortality or discharge for palliative care within 21 days of 3 hospitalization. Patients were considered event-free for the follow-up period of 21 days, if 4 they were discharged to home or a nursing facility. 5 Statistical analysis 6 We determined age-adjusted odds ratios (ORs) for each ethnicity for COVID-19 7 hospitalization by comparing the number of hospitalized COVID-19 patients to the general 8 population of Amsterdam and Almere. ORs were determined by calculating the ratio between 9 the odds for hospitalization in each ethnic group and the odds for the Dutch group, which was 10 taken as reference. Age adjustment was performed using the Cochran-Mantel-Haenszel 11 method; by partitioning age into <40; 40-50; 51-60; 61-70 and >70. We additionally 12 performed a descriptive analysis of ethnic differences in medical history and presentation at 13 the emergency department.

14 To assess ethnic differences in comorbid conditions between hospitalized COVID-19 15 patients and the risk of hospitalization, we matched COVID-19 patients from the COVID-16 predict database to HELIUS participants with complete data on comorbidities matched for 17 ethnicity and a nearest neighbour match for age and sex with a 1:2 ratio between cases and 18 controls. Using a logistic regression model with each comorbidity, ethnicity and their 19 interaction term, we assessed whether there were ethnic differences in the relation between 20 hypertension, diabetes, obesity, chronic kidney disease, history of chronic pulmonary disease 21 and malignancy and hospital admission. We then calculated the OR for hospitalization for 22 each comorbidity in the complete cohort and in groups stratified by ethnicity.

For the analysis of ethnic differences in outcomes during 21 days following 24 hospitalization (third research question), we performed a survival analysis using Kaplan-

latter was included to account for treatment and presentation differences during the ongoing 2 pandemic. We performed a sensitivity analysis using only patients admitted before (first 3 wave) and after September 1th, 2020, (second wave) respectively. All statistical analyses were 4 conducted with R version 3.6.1 (Vienna, Austria). For CovidPredict, we used data collected from the electronic health record. A waiver for the 7 use of hospital record data was obtained from the Medical Ethical Committees of the 8 participating centers and patients were given the opportunity to opt out. The HELIUS study 9 protocols were approved by the Ethical Review Board of Amsterdam UMC, location AMC 10 (NL32251.018.10). All participants provided written informed consent for participation in the 11 HELIUS study.

Demographics and patient characteristics 15 We included 1439 patients, admitted between 18 th February, 2020 and 30 th January, 2021, 16 with 826 patients (57%) admitted during the first wave (i.e., before 1 st September, 2020). An 17 overview of the inclusion stratified by hospital is given in Supplementary were female with the highest proportion among African-Surinamese (50%) and the lowest The risk for COVID-19 hospitalization among the population was significantly increased in 9 all ethnic minority groups compared to Dutch ( Figure 1 ). Ghanaians had the highest odds for 10 COVID-19 hospitalization; with an age-adjusted OR of 4.5(95%CI 3.2-6.0); while for all 11 other ethnic minority groups the odds ranged between 2.1 and 3.7 (Supplementary Table 2 ).

Overall, the prevalence of comorbidities was significantly higher in hospitalized patients 14 compared to their matched controls. The association between each comorbidity and hospital 15 admission differed significantly between ethnic groups ( Figure 2 ). We observed the highest 16 OR of 3.4 (2.6-4.3) between diabetes and COVID-19 hospitalization in the Dutch origin 17 group. In South-Asian Surinamese, who had the highest prevalence of diabetes among 18 controls (41.1%), we did not observe an increased OR for diabetes in hospitalized patients.

Obesity, on the other hand, was significantly associated with hospitalization in the South-20 Asian Surinamese group, with an OR of 3.2 (95%CI 1.5-6.6). For African Surinamese, ORs 21 were similar to those in the Dutch origin group, except for asthma and COPD. In the 22 Ghanaian subgroup, we found that hypertension and chronic kidney disease were associated 23 with hospitalization, with an OR of 4.8 (95%CI 2.1-11.6) and 4.8 (95%CI, 1.8-14.0), 24 respectively. In the Turkish group, we observed a high prevalence of obesity amongst both

cases (53.3%) and controls (57.9%), leading to an OR of 0.8 (95%CI 0.5-1.5). In Moroccan 1 participants, we found the lowest OR for diabetes, chronic kidney disease and asthma/COPD 2 compared to the other groups (Supplementary Table 3 ).

Ethnic differences in outcomes following hospitalization 4 We included 1178 patients in the survival analysis after exclusion of patients with other or 5 missing ethnicity. During 21-day follow-up; 169 (14.3%) patients died. 58 (4.9%) of the 6 patients were transferred to another hospital and outcome data were missing in 16 patients 7 (1.4%). A total of 206 (17.5%) of the patients were admitted to the ICU. Figure 3 shows the 8 Kaplan-Meier curves stratified by ethnicity, without adjustment for confounders. Mortality 9 was highest in patients from Dutch origin (17.3%), South-Asian Surinamese (15.1%) and 10 African Surinamese (12.1%) at 21 days following hospitalisation (table 2). After adjustment 11 for sex, age and time in the pandemic there were no significant differences between the ethnic 12 groups (p=0.66). The incidence rate for the composite outcome of ICU admission and 13 mortality ranged from 25.4% to 29.5%. In both unadjusted (p=0.95) and adjusted (p=0.99) 14 analyses there were no statistically significant differences between the ethnic groups. These 15 results were similar during the first and second wave (Supplementary Table 4 ). The relative high risk of COVID-19 hospitalization among ethnic minority groups in our 24 study is consistent with the findings from the UK and the USA; and corroborates with the 25 higher rates of SARS-CoV-2 infections diagnosed among these populations. [20, 21] The

relatively high rates of COVID-19 hospitalization among ethnic minority groups infected with 1 COVID-19 have been attributed to numerous factors including a higher infection rate in these 2 groups. A study among a subsample of respondents of the HELIUS study has confirmed this 3 hypothesis for the population in Amsterdam as well. [21] 4 In addition to the higher incidence of infections, an increased risk of severe COVID-19 5 disease in ethnic minority groups might explain their higher risk of hospital admission, 6 potentially driven by high burden of pre-existing comorbidities, [22] [23] [24] poor access to health 7 education in prevention measures, and delay in seeking healthcare potentially due to several 8 factors such as language barriers, misinformation and lack of trust in public officials. [25, 26] 9 Evidence indicates that the risk of COVID-19 hospitalization is higher in individuals with pre-10 existing comorbidities than those without comorbidities. [27, 28] In our study, we found that 11 the prevalence of comorbid conditions was significantly higher in COVID-19 hospitalized following COVID-19 hospitalization seems to suggest that the higher mortality observed in 3 ethnic minority groups in the Netherlands is not as a result of a poorer prognosis following 4 hospitalization, but rather a higher chance of being hospitalized possibly due to a higher 5 incidence of infections and a higher risk of serious illness from COVID-19 infection. [20, 41] 6 Our current findings suggest that the increased risk of severe COVID-19 disease may in part 7 be attributable to comorbid conditions that can be prevented by targeted health promotion 8 measures and health care interventions that aim at mitigating ethnic inequalities in these 9 conditions. 13 data on COVID hospitalization from the regional public health service[42] during the first 1 wave showed similar results compared to the data derived from the hospital databases in our 2 study. Moreover, some of the measures such as previous malignancy status were based on 3 self-reported data. Lastly, although combining HELIUS with hospital data was a key strength 4 of our study, the sample sizes of the subgroups were still relatively small making it difficult to 5 assess the interaction between ethnicity and comorbidities. Despite these limitations, our 6 study provides new comprehensive data on inequalities in COVID-19 hospitalization and 7 prognosis among major ethnic minority groups in Europe in whom data are currently lacking.

In conclusion, our study findings indicate that the risk of COVID-19 hospitalization is higher 9 in ethnic minority groups than in the population of Dutch origin. Our findings suggest that We would like to thank the CovidPredict consortium (www.covidpredict.org) for their efforts 4 in providing the patient data. 

CRP (mg/L), median (IQR)

Time between hospitalization and March 2020 (days), median

Time between onset of symptoms and admission (days)